Newswire

Newswire

Current Water Technologies Grants Stock Options

GUELPH, Ontario, Jan. 13, 2023 (GLOBE NEWSWIRE) — Current Water Technologies Inc. (TSX-V: WATR) (“CWTI” or “the Company”) announces that it has granted 1,000,000 incentive stock options to 2 consultants, 4,000,000 to 10 employees and 2,825,000 to 4 directors. The…

Blender Bites Announces Approval of Forward Share Split

VANCOUVER, British Columbia, Jan. 13, 2023 (GLOBE NEWSWIRE) — Blender Bites Ltd. (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL4, WKN: A3C3Y2), a Canadian company involved in the development and marketing of a line of premium, organic and plant-based pre-portioned…

Non-Animal Alternatives Testing Market Works On 3D-Printed Organs For Clinical Trials As Per The Business Research Company’s Non-Animal Alternatives Testing Global Market Report 2023

LONDON, Jan. 13, 2023 (GLOBE NEWSWIRE) — According to The Business Research Company’s research report on the non-animal alternatives testing market, use of 3D-printed organs is an important trend in the non-animal alternatives testing market. 3D-printed organs involve a fusion…

Everest Medicines Enters into a Global Licensing Agreement to Develop and Commercialize Singapore’s Experimental Drug Development Centre’s 3CL Protease Inhibitors as Potentially Best-in-Class COVID-19 Oral Antiviral Treatments Worldwide

SHANGHAI, Jan. 13, 2023 /PRNewswire/ — Everest Medicines(HKEX 1952.HK, “Everest”, or the “Company”), and Singapore’s Experimental Drug Development Centre (“EDDC”) today announced a global licensing agreement under which Everest will obtain exclusive worldwide rights to develop, manufacture and commercialize EDDC’s…